Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy

• Main Authors: Alan Faraj (Author), Rob C. vanWijk (Author), Linda Neuman (Author), Shraddha Desai (Author), Grant E. Blouse (Author), Tom Knudsen (Author), Ulrika S. H. Simonsson (Author)
• Format: Book
• Published: Wiley, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Marzeptacog alfa (activated) (MarzAA) is an activated recombinant human rFVII variant intended for subcutaneous (s.c.) administration to treat or prevent bleeding in individuals with hemophilia A (HA) or B (HB) with inhibitors, and other rare bleeding disorders. The s.c. administration prov...